Deepak Kilari, MD
Hematology & Oncology · Milwaukee, WINPI 1164652947
Payments from drug & device makers
Across 954 payments — averaging $4894.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Exelixis Inc.$1.2M
- Novartis$704K
- Merck$691K
- Amgen$231K
- Seagen Inc.$214K
- Boehringer Ingelheim International GmbH$209K
- plus $1.4M from 20 others
Across 14 payments — averaging $932.44 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$12K
- Regeneron$2K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Exelixis Inc. | 105 | $1,202,329 |
| Novartis | 10 | $703,633 |
| Merck | 95 | $691,275 |
| Amgen | 2 | $231,285 |
| Seagen Inc. | 61 | $213,639 |
| Boehringer Ingelheim International GmbH | 53 | $209,408 |
| Regeneron | 109 | $190,087 |
| AstraZeneca | 21 | $162,939 |
| Janssen Research & Development, LLC | 1 | $161,501 |
| Bayer | 54 | $123,241 |
| Genentech, Inc. | 11 | $112,785 |
| Pfizer | 88 | $100,405 |
| AVEO Pharmaceuticals, Inc. | 72 | $92,970 |
| Astellas Pharma Global Development | 19 | $87,373 |
| Johnson & Johnson | 69 | $82,829 |
| Teva Pharmaceuticals USA, Inc. | 7 | $68,788 |
| Eisai Inc. | 58 | $68,490 |
| Kyowa Kirin, Inc. | 44 | $48,840 |
| Clovis Oncology, Inc. | 12 | $38,249 |
| Kyowa Kirin Pharmaceutical Development, Inc | 8 | $23,005 |
| Astellas Pharma US Inc | 22 | $22,042 |
| Medivation LLC. | 19 | $21,002 |
| Sanofi | 9 | $11,798 |
| Janssen Scientific Affairs, LLC | 3 | $1,672 |
| Tempus AI, Inc | 1 | $100 |
| Astellas Pharma Europe Ltd | 1 | $61 |
How this compares
$4,669,745 in reported general payments places this provider in the 95th percentile of 248 hematology & oncology providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other hematology & oncology in Milwaukee
- Binod DhakalMilwaukee$13.9M
- Ehab AtallahMilwaukee$13.3M
- Guru Subramanian Guru MurthyMilwaukee$7.2M
- Parameswaran HariMilwaukee$5.8M
- Meera MohanMilwaukee$5.6M
- Kathryn BylowMilwaukee$4.5M
- Sayed Mehdi HamadaniMilwaukee$3.7M
- Anita DsouzaMilwaukee$3.7M
- Sameem AbedinMilwaukee$3.3M
- Wael SaberMilwaukee$2.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.